Overexpression of transferrin receptor CD71 and its tumorigenic properties in esophageal squamous cell carcinoma

Oncology Reports

Volumn 31, Issue 3, 2014, Pages 1296-1304

  Chan, Kin Tak ^a   Choi, Mei Yuk ^a   Lai, Kenneth K Y ^a   Tan, Winnie ^a   Tung, Lai Nar ^a   Lam, H O Y U ^a   Tong, Daniel K H ^a   Lee, Nikki P ^a   Law, Simon ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

CD71; Esophageal squamous cell carcinoma; siRNA; Transferrin receptor

Indexed keywords

CD71 ANTIGEN; KI 67 ANTIGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA;

ADVANCED CANCER; AGED; ARTICLE; CANCER STAGING; CARCINOGENESIS; CD71 GENE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; S PHASE CELL CYCLE CHECKPOINT; SIGNAL TRANSDUCTION; TUMOR DIFFERENTIATION; TUMOR GENE; UPREGULATION;

AGED; ANTIGENS, CD; CARCINOGENESIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; NEOPLASM STAGING; RECEPTORS, TRANSFERRIN; RNA, SMALL INTERFERING;

EID: 84896706759     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.2981     Document Type: Article

References (43)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Law S, Kwong DL, Kwok KF, et al: Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy. Ann Surg 238: 339-348, 2003. (Pubitemid 38174477)
3. Law S and Wong J: The current management of esophageal cancer. Adv Surg 41: 93-119, 2007.
4. Chen X, Yang G, Ding WY, Bondoc F, Curtis SK and Yang CS: An esophagogastroduodenal anastomosis model for esophageal adenocarcinogenesis in rats and enhancement by iron overload. Carcinogenesis 20: 1801-1808, 1999.
5. Cross AJ, Freedman ND, Ren J, et al: Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol 106: 432-442, 2011.
6. Boult J, Roberts K, Brookes MJ, et al: Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma. Clin Cancer Res 14: 379-387, 2008. (Pubitemid 351226104)
7. Desoize B: Metals and metal compounds in cancer treatment. Anticancer Res 24: 1529-1544, 2004.
8. Sanchez M, Galy B, Dandekar T, et al: Iron regulation and the cell cycle: identification of an iron-responsive element in the 3′-untranslated region of human cell division cycle 14A mRNA by a refined microarray-based screening strategy. J Biol Chem 281: 22865-22874, 2006.
9. Brookes MJ, Boult J, Roberts K, et al: A role for iron in Wnt signalling. Oncogene 27: 966-975, 2008. (Pubitemid 351225389)
10. Song S, Christova T, Perusini S, et al: Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers. Cancer Res 71: 7628-7639, 2011.
11. Munoz P, Zavala G, Castillo K, Aguirre P, Hidalgo C and Nunez MT: Effect of iron on the activation of the MAPK/ERK pathway in PC12 neuroblastoma cells. Biol Res 39: 189-190, 2006. (Pubitemid 44027660)
12. Yu Y and Richardson DR: Cellular iron depletion stimulates the JNK and p38 MAPK signaling transduction pathways, dissociation of ASK1-thioredoxin, and activation of ASK1. J Biol Chem 286: 15413-15427, 2011.
13. Kaomongkolgit R, Cheepsunthorn P, Pavasant P and Sanchavanakit N: Iron increases MMP-9 expression through activation of AP-1 via ERK/Akt pathway in human head and neck squamous carcinoma cells. Oral Oncol 44: 587-594, 2008. (Pubitemid 351681968)
14. Kukulj S, Jaganjac M, Boranic M, Krizanac S, Santic Z and Poljak-Blazi M: Altered iron metabolism, inflammation, transferrin receptors, and ferritin expression in non-small-cell lung cancer. Med Oncol 27: 268-277, 2010.
15. Habashy HO, Powe DG, Staka CM, et al: Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 119: 283-293, 2010.
16. Jiang XP, Elliott RL and Head JF: Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas. Anticancer Res 30: 759-765, 2010.
17. Magro G, Cataldo I, Amico P, et al: Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. Thyroid 21: 267-277, 2011.
18. Testa U, Pelosi E and Peschle C: The transferrin receptor. Crit Rev Oncog 4: 241-276, 1993.
19. Aisen P: Transferrin receptor 1. Int J Biochem Cell Biol 36: 2137-2143, 2004.
20. Sargent PJ, Farnaud S and Evans RW: Structure/function overview of proteins involved in iron storage and transport. Curr Med Chem 12: 2683-2693, 2005. (Pubitemid 41601567)
21. Prutki M, Poljak-Blazi M, Jakopovic M, Tomas D, Stipancic I and Zarkovic N: Altered iron metabolism, transferrin receptor 1 and ferritin in patients with colon cancer. Cancer Lett 238: 188-196, 2006. (Pubitemid 43867908)
22. Wada S, Noguchi T, Takeno S and Kawahara K: PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma. Ann Surg Oncol 13: 961-966, 2006.
23. Hu Y, Lam KY, Wan TS, et al: Establishment and characterization of HKESC-1, a new cancer cell line from human esophageal squamous cell carcinoma. Cancer Genet Cytogenet 118: 112-120, 2000. (Pubitemid 30169212)
24. Hu YC, Lam KY, Law SY, et al: Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genet Cytogenet 135: 120-127, 2002. (Pubitemid 34786763)
25. Tang JC, Wan TS, Wong N, et al: Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genet Cytogenet 124: 36-41, 2001. (Pubitemid 32101470)
26. Zhang H, Jin Y, Chen X, et al: Cytogenetic aberrations in immortalization of esophageal epithelial cells. Cancer Genet Cytogenet 165: 25-35, 2006. (Pubitemid 43254649)
27. Hui MK, Chan KW, Luk JM, et al: Cytoplasmic Forkhead Box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg 36: 90-97, 2012.
28. Hui MK, Lai KK, Chan KW, et al: Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. Med Oncol 29: 1699-1706, 2012.
29. Lee NP, Leung KW, Wo JY, Tam PC, Yeung WS and Luk JM: Blockage of testicular connexins induced apoptosis in rat seminiferous epithelium. Apoptosis 11: 1215-1229, 2006. (Pubitemid 44035969)
30. Lee NP, Tsang FH, Shek FH, et al: Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma. Int J Cancer 127: 968-976, 2010.
31. Chan KT and Lung ML: Mutant p53 expression enhances drug resistance in a hepatocellular carcinoma cell line. Cancer Chemother Pharmacol 53: 519-526, 2004.
32. Liu LX, Lee NP, Chan VW, et al: Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50: 1453-1463, 2009.
33. Hanninen MM, Haapasalo J, Haapasalo H, et al: Expression of iron-related genes in human brain and brain tumors. BMC Neurosci 10: 36, 2009.
34. Ryschich E, Huszty G, Knaebel HP, Hartel M, Buchler MW and Schmidt J: Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreas. Eur J Cancer 40: 1418-1422, 2004. (Pubitemid 38737029)
35. Sciot R, Paterson AC, van Eyken P, Callea F, Kew MC and Desmet VJ: Transferrin receptor expression in human hepatocellular carcinoma: an immunohistochemical study of 34 cases. Histopathology 12: 53-63, 1988.
36. Cmejla R, Petrak J and Cmejlova J: A novel iron responsive element in the 3′ UTR of human MRCKα. Biochem Biophys Res Commun 341: 158-166, 2006. (Pubitemid 43117400)
37. Cmejla R, Ptackova P, Petrak J, et al: Human MRCKα is regulated by cellular iron levels and interferes with transferrin iron uptake. Biochem Biophys Res Commun 395: 163-167, 2010.
38. Schaar DG, Medina DJ, Moore DF, Strair RK and Ting Y: miR-320 targets transferrin receptor 1 (CD71) and inhibits cell proliferation. Exp Hematol 37: 245-255, 2009.
39. Ford SJ, Obeidy P, Lovejoy DB, et al: Deferasirox (ICL670A) effectively inhibits oesophageal cancer growth in vitro and in vivo. Br J Pharmacol 168: 1316-1328, 2013.
40. Loisel S, Andre PA, Golay J, et al: Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia. Mol Cancer 10: 42, 2011.
41. Du H, Yao W, Fang M and Wu D: ARF triggers cell G1 arrest by a P53 independent ERK pathway. Mol Cell Biochem 357: 415-422, 2011.
42. McCubrey JA, Steelman LS, Chappell WH, et al: Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochim Biophys Acta 1773: 1263-1284, 2007. (Pubitemid 47125967)
43. Sahu RP, Zhang R, Batra S, Shi Y and Srivastava SK: Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells. Carcinogenesis 30: 1744-1753, 2009.